Arena's Lorcaserin Reaches FDA, But Without REMS Proposal
Executive Summary
Arena Pharmaceuticals filed the NDA for its obesity drug lorcaserin Dec. 22, crossing the top item off the firm's news flow list and refocusing attention on the drug's partnering potential in a shifting regulatory and competitive landscape
You may also be interested in...
Arena Gets Financing Boost, Lorcaserin Advisory Committee Date
Deerfield takes a $35.5 million equity stake, but finding a commercialization partner is still Arena's focus as it prepares for the September 16 panel review of its obesity drug.
Business News In Brief
Sandoz names DeGolyer head of U.S. business: Sandoz appointed Don DeGolyer President of its U.S. business unit, replacing Christine Mundkur who is leaving to pursue other opportunities, the drug maker announced March 8. Mundkur served a short role at the company after leaving her position as chief executive of Barr to shape up Sandoz's U.S. operation and grow the generics business in early 2009 (1"The Pink Sheet," Feb. 16, 2009). DeGolyer most recently held the position of senior VP and head of U.S. Commercial Operations for Sandoz US. At the same time, Sandoz also appoints Richard Tremonte VP of U.S. Retail Sales and Marketing, from his post as senior director of marketing for Sandoz U.S., which he held after joining the company in 2007
Business News In Brief
Sandoz names DeGolyer head of U.S. business: Sandoz appointed Don DeGolyer President of its U.S. business unit, replacing Christine Mundkur who is leaving to pursue other opportunities, the drug maker announced March 8. Mundkur served a short role at the company after leaving her position as chief executive of Barr to shape up Sandoz's U.S. operation and grow the generics business in early 2009 (1"The Pink Sheet," Feb. 16, 2009). DeGolyer most recently held the position of senior VP and head of U.S. Commercial Operations for Sandoz US. At the same time, Sandoz also appoints Richard Tremonte VP of U.S. Retail Sales and Marketing, from his post as senior director of marketing for Sandoz U.S., which he held after joining the company in 2007